Incidental Mutation 'R6933:Tspyl3'
ID 540146
Institutional Source Beutler Lab
Gene Symbol Tspyl3
Ensembl Gene ENSMUSG00000074671
Gene Name TSPY-like 3
Synonyms LOC241732
MMRRC Submission 045048-MU
Accession Numbers
Essential gene? Probably non essential (E-score: 0.084) question?
Stock # R6933 (G1)
Quality Score 214.009
Status Validated
Chromosome 2
Chromosomal Location 153064290-153067361 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) T to C at 153067203 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Threonine to Alanine at position 12 (T12A)
Ref Sequence ENSEMBL: ENSMUSP00000096799 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000056924] [ENSMUST00000099194] [ENSMUST00000109795]
AlphaFold Q3UYP3
Predicted Effect probably benign
Transcript: ENSMUST00000056924
SMART Domains Protein: ENSMUSP00000055709
Gene: ENSMUSG00000051413

DomainStartEndE-ValueType
ZnF_C2H2 68 92 5.99e-4 SMART
ZnF_C2H2 98 120 1.03e-2 SMART
ZnF_C2H2 127 149 1.36e-2 SMART
ZnF_C2H2 156 178 6.23e-2 SMART
ZnF_C2H2 191 213 1.26e-2 SMART
ZnF_C2H2 219 242 3.11e-2 SMART
low complexity region 324 340 N/A INTRINSIC
low complexity region 369 397 N/A INTRINSIC
low complexity region 417 432 N/A INTRINSIC
low complexity region 443 458 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000099194
AA Change: T12A

PolyPhen 2 Score 0.000 (Sensitivity: 1.00; Specificity: 0.00)
SMART Domains Protein: ENSMUSP00000096799
Gene: ENSMUSG00000074671
AA Change: T12A

DomainStartEndE-ValueType
low complexity region 41 52 N/A INTRINSIC
low complexity region 76 90 N/A INTRINSIC
Pfam:NAP 160 307 2.9e-23 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000109795
SMART Domains Protein: ENSMUSP00000105419
Gene: ENSMUSG00000051413

DomainStartEndE-ValueType
ZnF_C2H2 68 92 5.99e-4 SMART
ZnF_C2H2 98 120 1.03e-2 SMART
ZnF_C2H2 127 149 1.36e-2 SMART
ZnF_C2H2 156 178 6.23e-2 SMART
ZnF_C2H2 191 213 1.26e-2 SMART
ZnF_C2H2 219 242 3.11e-2 SMART
low complexity region 324 340 N/A INTRINSIC
low complexity region 369 397 N/A INTRINSIC
low complexity region 417 432 N/A INTRINSIC
low complexity region 443 458 N/A INTRINSIC
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 99.9%
  • 10x: 99.2%
  • 20x: 97.7%
Validation Efficiency 93% (41/44)
Allele List at MGI
Other mutations in this stock
Total: 44 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Ank3 G T 10: 69,740,042 (GRCm39) K814N probably damaging Het
Anks1b A G 10: 89,905,352 (GRCm39) H231R probably damaging Het
Anks6 A G 4: 47,049,164 (GRCm39) V247A probably benign Het
Antxrl A G 14: 33,797,728 (GRCm39) N568D possibly damaging Het
Ccnl1 T C 3: 65,855,373 (GRCm39) T366A probably benign Het
Ccr2 T G 9: 123,906,161 (GRCm39) L147R probably damaging Het
Cdc40 A G 10: 40,720,992 (GRCm39) V318A probably damaging Het
Cfap61 T A 2: 145,792,970 (GRCm39) probably null Het
Cfap97d2 CA CAA 8: 13,784,865 (GRCm39) probably null Het
Clk3 A T 9: 57,669,132 (GRCm39) Y31N probably damaging Het
Cmya5 T C 13: 93,231,644 (GRCm39) Y1148C probably benign Het
Cntnap5b T C 1: 100,311,175 (GRCm39) V927A probably benign Het
Dync1i1 A C 6: 5,913,333 (GRCm39) T217P probably damaging Het
Elovl4 A G 9: 83,667,153 (GRCm39) V68A probably damaging Het
Ep400 C A 5: 110,813,728 (GRCm39) K2890N probably damaging Het
Fam114a2 T C 11: 57,374,897 (GRCm39) I481V probably benign Het
Fam83e A G 7: 45,371,818 (GRCm39) T72A probably benign Het
Fnip2 A T 3: 79,425,418 (GRCm39) M59K probably benign Het
Lrpprc T C 17: 85,030,131 (GRCm39) K1089R probably benign Het
Mndal T A 1: 173,703,249 (GRCm39) E52V probably damaging Het
Myom1 C A 17: 71,359,666 (GRCm39) T446K probably damaging Het
Nbea A T 3: 55,631,031 (GRCm39) F2199I possibly damaging Het
Nr1h2 A T 7: 44,199,437 (GRCm39) L438Q probably damaging Het
Or52n2c A G 7: 104,574,330 (GRCm39) C214R probably benign Het
Pet117 T A 2: 144,211,019 (GRCm39) V13E possibly damaging Het
Pnpla8 A G 12: 44,330,210 (GRCm39) E254G probably benign Het
Polr2a T C 11: 69,627,003 (GRCm39) E1485G probably damaging Het
Polr2a C T 11: 69,630,293 (GRCm39) R1258Q probably benign Het
Ptpn4 T C 1: 119,700,878 (GRCm39) probably benign Het
Rapgef2 A T 3: 78,993,266 (GRCm39) Y889N probably damaging Het
Sbf1 G A 15: 89,184,572 (GRCm39) R1115C probably damaging Het
Sfpq GCCGCCGCAGCAGCCTCCGCCGCAGCAGCC GCCGCCGCAGCAGCC 4: 126,915,419 (GRCm39) probably benign Het
Shank2 A T 7: 143,645,515 (GRCm39) T366S probably benign Het
Slc22a23 T C 13: 34,489,163 (GRCm39) I241V probably benign Het
Sox11 G T 12: 27,391,493 (GRCm39) S305R probably damaging Het
Sox21 T C 14: 118,472,725 (GRCm39) H108R possibly damaging Het
Taok1 A T 11: 77,446,479 (GRCm39) S417T probably benign Het
Tg C T 15: 66,636,158 (GRCm39) R582C possibly damaging Het
Traf3 T C 12: 111,221,658 (GRCm39) V273A possibly damaging Het
Vmn2r86 A T 10: 130,282,126 (GRCm39) I830N probably damaging Het
Vps26b A T 9: 26,926,613 (GRCm39) F129I possibly damaging Het
Washc3 A G 10: 88,037,714 (GRCm39) N24S probably damaging Het
Xirp2 C A 2: 67,345,201 (GRCm39) Q2481K probably benign Het
Zfhx4 T C 3: 5,478,047 (GRCm39) V3554A probably damaging Het
Other mutations in Tspyl3
AlleleSourceChrCoordTypePredicted EffectPPH Score
F5770:Tspyl3 UTSW 2 153,066,980 (GRCm39) missense probably benign 0.07
R0035:Tspyl3 UTSW 2 153,066,240 (GRCm39) missense probably damaging 1.00
R0866:Tspyl3 UTSW 2 153,066,854 (GRCm39) missense probably damaging 1.00
R1780:Tspyl3 UTSW 2 153,067,176 (GRCm39) missense probably damaging 0.97
R1930:Tspyl3 UTSW 2 153,066,717 (GRCm39) missense probably damaging 1.00
R3015:Tspyl3 UTSW 2 153,066,650 (GRCm39) missense probably damaging 1.00
R4296:Tspyl3 UTSW 2 153,067,076 (GRCm39) missense possibly damaging 0.96
R5913:Tspyl3 UTSW 2 153,066,636 (GRCm39) missense probably benign 0.17
V7580:Tspyl3 UTSW 2 153,066,980 (GRCm39) missense probably benign 0.07
V7581:Tspyl3 UTSW 2 153,066,980 (GRCm39) missense probably benign 0.07
V7583:Tspyl3 UTSW 2 153,066,980 (GRCm39) missense probably benign 0.07
Predicted Primers PCR Primer
(F):5'- CAGCCATCCAGGTTCAGAAC -3'
(R):5'- CCAGTTCTGTTTGACTCAGGTG -3'

Sequencing Primer
(F):5'- ATCCAGGTTCAGAACGCGGG -3'
(R):5'- CAGTGGAGTGACTCTAGCAAGTC -3'
Posted On 2018-11-06